A detailed history of Allspring Global Investments Holdings, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 86,214 shares of INVA stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,214
Previous 90,914 5.17%
Holding current value
$1.53 Million
Previous $1.49 Million 11.61%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$16.33 - $20.04 $76,750 - $94,188
-4,700 Reduced 5.17%
86,214 $1.66 Million
Q2 2024

Jul 26, 2024

SELL
$14.4 - $16.4 $298,728 - $340,217
-20,745 Reduced 18.58%
90,914 $1.49 Million
Q1 2024

Apr 18, 2024

BUY
$14.56 - $16.78 $227,063 - $261,684
15,595 Added 16.23%
111,659 $1.7 Million
Q4 2023

Jan 25, 2024

SELL
$12.32 - $16.27 $689,673 - $910,794
-55,980 Reduced 36.82%
96,064 $1.54 Million
Q3 2023

Oct 27, 2023

BUY
$12.37 - $13.89 $1.88 Million - $2.11 Million
152,044 New
152,044 $1.98 Million
Q2 2023

Jul 18, 2023

SELL
$11.39 - $13.72 $886,517 - $1.07 Million
-77,833 Reduced 26.3%
218,084 $2.78 Million
Q1 2023

Apr 13, 2023

BUY
$10.73 - $13.6 $266,801 - $338,164
24,865 Added 9.17%
295,917 $3.33 Million
Q4 2022

Jan 23, 2023

BUY
$11.8 - $13.78 $2.6 Million - $3.04 Million
220,734 Added 438.68%
271,052 $0
Q3 2022

Oct 26, 2022

SELL
$11.61 - $15.22 $14,466 - $18,964
-1,246 Reduced 2.42%
50,318 $584,000
Q2 2022

Jul 25, 2022

SELL
$14.32 - $19.88 $5.74 Million - $7.97 Million
-400,837 Reduced 88.6%
51,564 $761,000
Q1 2022

May 02, 2022

SELL
$15.39 - $20.25 $142,496 - $187,494
-9,259 Reduced 2.01%
452,401 $8.75 Million
Q4 2021

Jan 28, 2022

BUY
$15.91 - $18.72 $7.35 Million - $8.64 Million
461,660 New
461,660 $7.96 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.